Filing Details

Accession Number:
0001340610-14-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-09-03 17:17:38
Reporting Period:
2014-09-03
Filing Date:
2014-09-03
Accepted Time:
2014-09-03 17:17:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
93314 Volitionrx Ltd VNRX In Vitro & In Vivo Diagnostic Substances (2835) 911949078
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1340610 John Cameron Reynolds 1 Scotts Rd #24-05 Shaw Centre
U0 U0 228208
Ceo And President Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-09-03 900,000 $0.00 1,102,344 No 4 G Direct
Common Stock Disposition 2014-09-03 1,038,000 $0.00 1,004,088 No 4 S Indirect By Concord International, Inc.(1)
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 G Direct
No 4 S Indirect By Concord International, Inc.(1)
Footnotes
  1. The shares are held by Concord International, Inc. ("Concord") in trust. On September 3, 2014, Concord disposed of 1,038,000 total shares by gift and sale. The transaction was reported by Mr. Rodney Rootsaert and Concord on a Form 4 filed with the SEC on September 3, 2014. Mr. Reynolds is a potential beneficiary of the trust, however, any distribution will be determined by the trustee and there is not actual entitlement to a distribution of the shares.